Viewing Study NCT05067127


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-03-22 @ 11:50 AM
Study NCT ID: NCT05067127
Status: COMPLETED
Last Update Posted: 2025-08-06
First Post: 2021-09-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
Sponsor:
Organization: